Keymed Biosciences, Inc. had a revenue of 54.68M in the quarter ending Jun 30, 2024, with 102.74%. This bring the company's revenue in the last twelve months to 95.14M, Increased -74.12%. In the fiscal year ending Dec 31, 2023, Keymed Biosciences, Inc. had annual revenue of 354.10M with 253.87% growth.